SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the ROTH 22nd Annual Orange County Growth Stock Conferenceon Monday, March 15th in Laguna Niguel.
SuperGen's presentation will begin at 3:30 p.m. PT. A live webcast of the presentation will be available in the Investor Events section of the Company's Web site at www.supergen.com. The webcast will be archived for 30 days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.
Contacts:
SuperGen, Inc.
Timothy L. Enns, 925-560-2810
Senior Vice
President
Corporate Communications & Business Development
tenns@supergen.com
or
Susanna
Chau, 925-560-2845
Manager
Investor Relations
schau@supergen.com
